The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 1,030 | 12,312 | SH | SOLE | 0 | 0 | 12,312 | ||
| DOCUSIGN | COM | 256163106 | 12,058 | 56,021 | SH | SOLE | 0 | 0 | 56,021 | ||
| IVERIC BIO INC | COM | 46583P102 | 230 | 40,705 | SH | SOLE | 0 | 0 | 40,705 | ||
| JBG SMITH COM | COM | 46590V100 | 47,058 | 1,759,817 | SH | SOLE | 0 | 0 | 1,759,817 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 3,158 | 90,758 | SH | SOLE | 0 | 0 | 90,758 | ||
| TRANSDIGM GROUP INC | COM | 893641100 | 11,311 | 23,807 | SH | SOLE | 0 | 0 | 23,807 | ||